Nutritional Supplement

Ginkgo

  • Eye Health Support

    Glaucoma

    In cases of normal tension glaucoma; ginkgo may help improve vision.
    Glaucoma
    ×
     

    In a double-blind study, supplementation with a standardized extract of Ginkgo biloba in the amount of 40 mg three times a day for four weeks partially reversed visual field damage in people with one type of glaucoma (normal tension glaucoma).9

    Macular Degeneration

    Taking ginkgo may help treat early stage macular degeneration.
    Macular Degeneration
    ×
     

    Ginkgo(Ginkgo biloba) may help treat early-stage macular degeneration, according to small, preliminary clinical trials.10 Many healthcare professionals recommend 120 to 240 mg of standardized extract (24% ginkgo flavone glycosides and 6% terpene lactones) in capsules or tablets per day.

    Retinopathy

    Using a standardized extract of ginkgo has been reported to improve visual function in people with mild diabetic retinopathy.
    Retinopathy
    ×
     

    The use of 160 mg per day of a standardized extract of Ginkgo biloba for six months has been reported in a small double-blind trial11 to improve impaired visual function in people with mild diabetic retinopathy.

  • Healthy Aging/Senior Health

    Age-Related Cognitive Decline

    Most, but not all, clinical trials have found this herb to be a safe and effective treatment for ARCD.
    Age-Related Cognitive Decline
    ×

    Most12,13,14,15,16,17,18,19 but not all20 clinical trials, many of them double-blind, have found ginkgo supplementation to be a safe and effective treatment for ARCD.21

    Macular Degeneration

    Taking ginkgo may help treat early stage macular degeneration.
    Macular Degeneration
    ×
     

    Ginkgo(Ginkgo biloba) may help treat early-stage macular degeneration, according to small, preliminary clinical trials.22 Many healthcare professionals recommend 120 to 240 mg of standardized extract (24% ginkgo flavone glycosides and 6% terpene lactones) in capsules or tablets per day.

    Alzheimer’s Disease

    Ginkgo biloba extract is an approved treatment for early-stage Alzheimer’s disease in Europe. It is thought to improve memory and quality of life and slow early disease progression.
    Alzheimer’s Disease
    ×

    An extract made from the leaves of the Ginkgo biloba tree is an approved treatment for early-stage Alzheimer’s disease in Europe. While not a cure, Ginkgo biloba extract may improve memory and quality of life and slow progression in the early stages of the disease. In addition, several double-blind trials have shown that ginkgo is helpful for people in early stages of Alzheimer’s disease, as well as for those experiencing another form of dementia known as multi-infarct dementia.23,24,25,26,27 Ginkgo has been found to be nearly as effective against Alzheimer's disease as donepezil, a prescription drug used to treat the condition.28 One trial reported no effect of ginkgo supplementation in the treatment of Alzheimer’s disease, vascular dementia or age-associated memory impairment.29 However, the results of this trial have been criticized, since analysis of the results does not separate those patients with Alzheimer’s disease or vascular dementia from those with age-associated memory impairment. A comparison of placebo-controlled trials of ginkgo for Alzheimer’s disease concluded that the herb compared favorably with two prescription drugs, donepezil and tacrine, commonly used to treat the condition.30 Research studies have used 120 to 240 mg of ginkgo, standardized to contain 6% terpene lactones and 24% flavone glycosides per day, generally divided into two or three portions. Ginkgo may need to be taken for six to eight weeks before desired actions are noticed. Ginkgo was not effective for preventing Alzheimer's disease in elderly volunteers with normal cognitive function or in those with mild cognitive impairment.31

  • Heart and Circulatory Health

    Intermittent Claudication

    Studies have reported that people with intermittent claudication see improvements in pain-free walking distance when supplementing with ginkgo.
    Intermittent Claudication
    ×
     

    Extensive studies have been done with Ginkgo biloba extracts (GBE) for treatment of intermittent claudication.32,33 Two double-blind trials found that 120 mg of GBE per day increased pain-free and total walking distance among people with intermittent claudication.34,35Similar results were seen in another double-blind trial using 160 mg of GBE per day.36 In yet another double-blind trial, two doses of ginkgo extract were compared for six months.37 The researchers studied 60 vs. 120 mg twice daily and found that, while both amounts resulted in significant improvements in pain-free walking distance, the improvements were more pronounced at the higher dose. One double-blind study found that ginkgo extract was not beneficial.38 However, that study lasted only three months, whereas the positive studies lasted six months. It may take longer than three months for ginkgo to have a beneficial effect in people with intermittent claudication.

    Atherosclerosis

    The herb Ginkgo biloba may reduce atherosclerosis risk by stopping platelets from sticking together too much. It also increases blood circulation to the brain, arms, and legs.
    Atherosclerosis
    ×
     

    Ginkgo may reduce the risk of atherosclerosis by interfering with a chemical the body sometimes makes in excess, called platelet activating factor (PAF).39 PAF stimulates platelets to stick together too much; ginkgo stops this from happening. Ginkgo also increases blood circulation to the brain, arms, and legs.40

    Garlic and ginkgo also decrease excessive blood coagulation. Both have been shown in double-blind41 and other controlled42 trials to decrease the overactive coagulation of blood that may contribute to atherosclerosis.

    Numerous medicinal plants and plant compounds have demonstrated an ability to protect LDL cholesterol from being damaged by free radicals. Garlic,43 ginkgo,44 and guggul45 are of particular note in this regard. Garlic and ginkgo have been most convincingly shown to protect LDL cholesterol in humans.

    Raynaud’s Disease

    The herb Ginkgo has been reported to improve the circulation in small blood vessels and reduce pain in people with Raynaud’s disease.
    Raynaud’s Disease
    ×

    Ginkgo biloba has been reported to improve the circulation in small blood vessels.46 For that reason, some doctors recommend ginkgo for people with Raynaud’s disease. One preliminary trial found that 160 mg of standardized ginkgo extract per day reduced pain in people with Raynaud’s disease.47 Larger clinical trials are needed to confirm ginkgo’s effectiveness for this condition. Ginkgo is often used as a standardized extract (containing 24% ginkgo flavone glycosides and 6% terpene lactones). Doctors who recommend use of ginkgo often suggest that people take 120–160 mg per day.

  • Brain Health

    Age-Related Cognitive Decline

    Most, but not all, clinical trials have found this herb to be a safe and effective treatment for ARCD.
    Age-Related Cognitive Decline
    ×

    Most48,49,50,51,52,53,54,55 but not all56 clinical trials, many of them double-blind, have found ginkgo supplementation to be a safe and effective treatment for ARCD.57

    Memory Enhancement

    Ginkgo may enhance cognitive performance in healthy older adults as well as people experiencing cognitive decline.
    Memory Enhancement
    ×
    The terpene lactones found in ginkgo extracts, known as ginkgolides and bilobalide, typically make up approximately 6% of the extract. They are associated with increasing circulation to the brain and other parts of the body and may exert a protective action on nerve cells.58 ginkgo regulates the tone and elasticity of blood vessels,59 making circulation more efficient.60 Ginkgo is also well-known for its effect on memory and thinking (cognitive function). It may enhance cognitive performance in healthy older adults,8 in people with age-related cognitive decline, and in people with Alzheimer’s disease.
  • Stress and Mood Management

    Depression

    Ginkgo may alleviate depression in elderly people not responding to antidepressant drugs.
    Depression
    ×
     

    Ginkgo biloba (240 mg per day) may alleviate depression in depressed elderly people not responding to antidepressant drugs.61 It is unknown if ginkgo could alleviate depression in other age groups. A small, preliminary trial has shown that ginkgo can reduce sexual problems caused by antidepressants like fluoxetine (Prozac), bupropion (Wellbutrin), venlafaxine (Effexor), and nefazodone (Serzone) in men and women.62 Double-blind trials are now needed to determine whether ginkgo is truly effective for this purpose.

  • Men's Health

    Erectile Dysfunction

    The herb Ginkgo appears to increase blood flow to the penis.
    Erectile Dysfunction
    ×
     

    Ginkgo biloba may help some men with ED by increasing blood flow to the penis. One double-blind trial found improvement in men taking 240 mg per day of a standardized Ginkgo biloba extract (GBE) for nine months.63 A preliminary trial, involving 30 men who were experiencing ED as a result of medication use (selective serotonin reuptake inhibitors and other medications), found that approximately 200 mg per day of GBE had a positive effect on sexual function in 76% of the men.64

  • Sexual Health

    Erectile Dysfunction

    The herb Ginkgo appears to increase blood flow to the penis.
    Erectile Dysfunction
    ×
     

    Ginkgo biloba may help some men with ED by increasing blood flow to the penis. One double-blind trial found improvement in men taking 240 mg per day of a standardized Ginkgo biloba extract (GBE) for nine months.65 A preliminary trial, involving 30 men who were experiencing ED as a result of medication use (selective serotonin reuptake inhibitors and other medications), found that approximately 200 mg per day of GBE had a positive effect on sexual function in 76% of the men.66

  • Ear Health Support

    Vertigo

    Taking ginkgo may help reduce symptoms.
    Vertigo
    ×
     

    In a preliminary clinical trial, a standardized extract of Ginkgo biloba (GBE) significantly reduced symptoms of vertigo in a group of elderly people with mild cognitive impairment.67 Participants were given 40 mg three times per day for one year. GBE has also been reported to significantly reduce vertigo of unknown cause in preliminary68 and double-blind69 trials. The amounts given were 120 mg and 160 mg per day, respectively, for three months.

    Tinnitus

    The herb ginkgo may be useful in treating tinnitus.
    Tinnitus
    ×
     

    Ginkgo biloba has been used to treat tinnitus, with mixed results.70 The largest placebo-controlled trial to date failed to find any effect of 150 mg per day of ginkgo extract in people with tinnitus.71 Two smaller, controlled trials have found that standardized ginkgo extract (120 mg per day, containing 24% flavone glycosides and 6% terpene lactones), was effective at relieving the symptoms of tinnitus.72,73 One trial failed to find ginkgo beneficial, but used less than 30 mg of ginkgo extract per day, an amount unlikely to have any therapeutic effect.74

    Ménière’s Disease

    Ginkgo has been reported to reduce symptoms of tinnitus, vertigo, and hearing loss due to unspecified inner ear disorders.
    Ménière’s Disease
    ×
     

    Although Ginkgo biloba extract (GBE) has not been studied specifically for its effects in MD, in preliminary studies it has been reported to reduce symptoms of tinnitus, vertigo, and hearing loss due to unspecified inner ear disorders.75 Controlled research using GBE is needed to determine whether it is a treatment option specifically for MD.

  • Blood Sugar and Diabetes Support

    Type 2 Diabetes

    Ginkgo may improve the efficacy of commonly used anti-diabetes medications. It also appears to help prevent and treat type 2 diabetes-related complications.
    Type 2 Diabetes
    ×
    Ginkgo (Ginkgo biloba) extract was found in a placebo-controlled trial to enhance the HbA1c-lowering effect of the widely used anti-diabetes drug metformin, while not directly altering metabolism of the drug.76 In another placebo-controlled trial that included participants whose type 2 diabetes was not well controlled by metformin, adding 120 mg per day of ginkgo resulted in greater reductions in HbA1c and fasting blood glucose and insulin levels, as well as body-mass index (BMI), waist circumference, and abdominal fat, after 90 days.77 Clinical research has shown ginkgo extract can improve kidney function in people with type 2 diabetes and early signs of nephropathy (kidney damage), and strengthen retinal blood flow in those with diabetic retinopathy (damage to the visual center of the eye).78,79 Treatment with the combination of ginkgo leaf plus a traditional Chinese herbal remedy (Liuwei Dihuang Pills) reduced the risks of developing retinopathy or nephropathy in a placebo-controlled trial that included 140 people with type 2 diabetes who were monitored for three years.80 Findings from animal studies suggests ginkgo may also have protective effects on nerve tissue and may be helpful in preventing and treating type 2 diabetes-related neuropathy (nerve dysfunction).81,82

    Retinopathy

    Using a standardized extract of ginkgo has been reported to improve visual function in people with mild diabetic retinopathy.
    Retinopathy
    ×
     

    The use of 160 mg per day of a standardized extract of Ginkgo biloba for six months has been reported in a small double-blind trial83 to improve impaired visual function in people with mild diabetic retinopathy.

    Type 1 Diabetes

    Ginkgo may improve metabolism and help prevent complications of type 1 diabetes.
    Type 1 Diabetes
    ×
    Ginkgo (Ginkgo biloba) extract may be useful to people with type 1 diabetes because of its abilities to raise antioxidant capacity and reduce inflammatory signaling. A standardized ginkgo extract was found to improve insulin production and glucose metabolism and decrease triglyceride levels in an animal model of type 1 diabetes.84 Preliminary evidence from a trial in subjects with long-standing type 1 diabetes suggests it may have a role in protecting vision.85 Other animal research and a single small, uncontrolled, pilot trial indicate ginkgo may protect nerve function and prove useful for prevention and treatment of diabetic nerve damage (neuropathy).86,87,88
  • Menstrual and PMS Support

    Premenstrual Syndrome

    Standardized herbal Ginkgo extract has been shown to alleviate PMS symptoms.
    Premenstrual Syndrome
    ×
     

    A double-blind trial has shown that standardized Ginkgo biloba extract, when taken daily from day 16 of one menstrual cycle to day 5 of the next menstrual cycle, alleviates congestive and psychological symptoms of PMS better than placebo.89 The trial used 80 mg of a ginkgo extract two times per day.

  • Pain Management

    Migraine Headache

    Ginkgo extract may also help because it inhibits the action of a substance known as platelet-activating factor, which may contribute to migraines.
    Migraine Headache
    ×
     

    Ginkgo biloba extract may also help because it inhibits the action of a substance known as platelet-activating factor,90 which may contribute to migraines. No clinical trials have examined its effectiveness in treating migraines, however.

  • Women's Health

    Premenstrual Syndrome

    Standardized herbal Ginkgo extract has been shown to alleviate PMS symptoms.
    Premenstrual Syndrome
    ×
     

    A double-blind trial has shown that standardized Ginkgo biloba extract, when taken daily from day 16 of one menstrual cycle to day 5 of the next menstrual cycle, alleviates congestive and psychological symptoms of PMS better than placebo.91 The trial used 80 mg of a ginkgo extract two times per day.

  • Allergy and Lung Support

    Asthma

    Supplementing with the herb Ginkgo biloba may improve asthma, as its extracts block the action of a compound that contributes to asthma symptoms.
    Asthma
    ×
     

    Ginkgo biloba extracts have been considered a potential therapy for asthma. This is because the extracts block the action of platelet-activating factor (PAF), a compound the body produces that in part causes asthma symptoms. A trial using isolated ginkgolides from ginkgo (not the whole extract) found they reduced asthma symptoms.92 A controlled trial used a highly concentrated tincture of ginkgo leaf and found this preparation helped decrease asthma symptoms.93 For asthma, 120 to 240 mg of standardized ginkgo or 3 to 4 ml of regular tincture three times daily can be used.

  • Skin Protection

    Vitiligo

    Taking ginkgo may help improve repigmentation of skin.
    Vitiligo
    ×
     

    In a double-blind study of 52 people with slowly spreading vitiligo, supplementation with Ginkgo biloba extract (standardized to contain 24% ginkgoflavonglycosides), in the amount of 40 mg three times per day for up to six months, resulted in marked to complete repigmentation in 40% of cases, compared with only 9% among those receiving a placebo.94 Ginkgo was also found to be effective in a preliminary trial.95

What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

Temp Title
×
Temp Text

Traditional Use (May Not Be Supported by Scientific Studies)

Medicinal use of ginkgo can be traced back almost 5,000 years in Chinese herbal medicine. The nuts of the tree were most commonly recommended and used to treat respiratory tract ailments. The use of the leaves is a modern development originating in Europe.

References

1. Drieu K. Preparation and definition of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic. Fünfgeld EW, ed. Berlin: Springer-Verlag, 32-6.

2. Ferrandini C, Droy-Lefaix MT, Christen Y, eds. Ginkgo biloba Extract (EGb 761) as a Free Radical Scavenger. Paris: Elsevier, 1993.

3. Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind, drug versus placebo study. Presse Med 1986;15:1556-8 [in French].

4. Lanthony P, Cosson JP. The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study. J Fr Ophtalmol 1988;11:671-4 [in French].

5. Krieglstein J. Neuroprotective properties of Ginkgo biloba—constituents. Zeitschrift Phytother 1994;15:92-6.

6. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan(Ginkgo biloba): Recent Results in Pharmacology and Clinic. Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.

7. Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung 1990;40:589-93.

8. Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 2000;6:219-29.

9. Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003;110:359-62.

10. Lebuisson DA, Leroy L, Reigal G. Treatment of senile macular degeneration with Ginkgo biloba extract: a preliminary double-blind study versus placebo. In Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic, Fünfgeld FW, ed. Berlin: Springer-Verlag, 1988, 231-6.

11. Lanthony P, Cosson JP. The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study. J Fr Ophtalmol 1988;11:671-4 [in French].

12. Allain H, Raoul P, Lieury A, et al. Effects of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993;15(3):549-58.

13. Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo-controlled study of Ginkgo biloba extract (‘tanakan') in elderly patients with mild to moderate memory impairment. Curr Med Res Opin 1991;12(6):350-5.

14. Brautigam MRH, Blommaert FA, Verleye G, et al. Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double-blind placebo-controlled study. Phytomedicine 1998;5:425-34.

15. Wesnes K, Simmons D, Rook M. A double-blind, placebo-controlled trial of Tanakan in the treatment of idiopathic impairment in the elderly. Human Psychopharmacol 1987;2:159-69.

16. Israel L, Dell'Accio E, Martin G, Hugonot R. Ginkgo biloba extract and memory training programs—comparative assessment on elderly outpatients. Psychologie Médicale 1987;19:1431-9.

17. Gräbel E. The influence of Ginkgo biloba extract (EGb 761) on mental performance: A double-blind study under computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med 1992;110:73-6.

18. Winther K, Randlov C, Rein E, Mehlsen J. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Ther Res 1998;59:881-8.

19. Gavrilova SI, Preuss UW, Wong JW, et al. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial. Int J Geriatr Psychiatry 2014;29:1087–95.

20. van Dongen M, van Rossum E, Kessels A, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000;48:1183-94.

21. Ihl R, Bachinskaya N, Korczyn AD, et al. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry 2011;26:1186-94.

22. Lebuisson DA, Leroy L, Reigal G. Treatment of senile macular degeneration with Ginkgo biloba extract: a preliminary double-blind study versus placebo. In Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic, Fünfgeld FW, ed. Berlin: Springer-Verlag, 1988, 231-6.

23. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278:1327-32.

24. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation. Hum Psychopharmacol 1994;9:215-22.

25. Kanowski S, Herrmann W, Stephan K, et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996;29:47-56.

26. Maurer K, Ihl R, Dierks T, Frolich L. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer's type. J Psychiatr Res 1997;31:645-55.

27. Bachinskaya N, Hoerr R, Ihl R. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial. Neuropsychiatr Dis Treat 2011;7:209-15.

28. Mazza M, Capuano A, Bria P, Mazza S. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Eur J Neurol 2006;13:981-5.

29. van Dongen M, van Rossum E, Kessels A, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000;48:1183-94.

30. Wettstein A. Cholinesterase inhibitors and Ginkgo extracts-are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine 2000;6:393-401.

31. DeKosky ST, Williamson JD, Fitzpatrick AL, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008;300:2253-62.

32. Schneider B. Ginkgo biloba extract in peripheral arterial disease. Meta-analysis of controlled clinical trials. Arzneimittelforschung 1992;42:428-36 [in German].

33. Peters H, Kieser M, Hölscher U. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761® on intermittent claudication—a placebo-controlled, double-blind multicenter trial. VASA 1998;27:106-10.

34. Bauer U. Six-month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittelforsschung 1984;34:716-20 [in German].

35. Blume J, Kieser M, Hölscher U. Placebo-controlled, double-blind study on the efficacy of Ginkgo biloba special extract EGb 761 in maximum-level trained patients with intermittent claudication. Vasa 1996;25:265-74.

36. Blume J, Kieser M, Hölscher U. Efficacy of Ginkgo biloba special extract EGb 761 in peripheral occlusive disease. Fortschr Med 1998;116:137-43.

37. Schweizer J, Hautmann C. Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. Arzneimittelforschung 1999;49:900-4.

38. Wang J, Zhou S, Bronks R, et al. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease. .Clin Rehabil 2007;21:579-86.

39. Braquet P, Touqui L, Shen TS, Vargaftig BB. Perspectives in platelet activating factor research. Pharmacol Rev 1987;39:97-210.

40. Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 119-28.

41. Kiesewetter H, Jung F, Mrowietz C, et al. Effects of garlic on blood fluidity and fibrinolytic activity: A randomised, placebo-controlled, double-blind study. Br J Clin Pract Suppl 1990;69:24-9.

42. Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung 1990;40:589-93.

43. Phelps S, Harris WS. Garlic supplementation and lipoprotein oxidation susceptibility. Lipids 1993;28(5):475-7.

44. Yan LJ, Droy-Lefaix MT, Packer L. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Comm 1995;212:360-6.

45. Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic, prevents oxidation of low density lipoprotein. Phytother Res 1997;11:291-4.

46. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340:1136-9 [review].

47. Clement JL, Livecchi G, Jimenez C, et al. Modifications vasomotrices des extrémités lors l'exposition à des conditions thermiques défavorables. Méthodologie et résultant de l'étude de l'extrait de Ginkgo biloba. Acutal Angiol 1982;7:3-8.

48. Allain H, Raoul P, Lieury A, et al. Effects of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993;15(3):549-58.

49. Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo-controlled study of Ginkgo biloba extract (‘tanakan') in elderly patients with mild to moderate memory impairment. Curr Med Res Opin 1991;12(6):350-5.

50. Brautigam MRH, Blommaert FA, Verleye G, et al. Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double-blind placebo-controlled study. Phytomedicine 1998;5:425-34.

51. Wesnes K, Simmons D, Rook M. A double-blind, placebo-controlled trial of Tanakan in the treatment of idiopathic impairment in the elderly. Human Psychopharmacol 1987;2:159-69.

52. Israel L, Dell'Accio E, Martin G, Hugonot R. Ginkgo biloba extract and memory training programs—comparative assessment on elderly outpatients. Psychologie Médicale 1987;19:1431-9.

53. Gräbel E. The influence of Ginkgo biloba extract (EGb 761) on mental performance: A double-blind study under computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med 1992;110:73-6.

54. Winther K, Randlov C, Rein E, Mehlsen J. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Ther Res 1998;59:881-8.

55. Gavrilova SI, Preuss UW, Wong JW, et al. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial. Int J Geriatr Psychiatry 2014;29:1087–95.

56. van Dongen M, van Rossum E, Kessels A, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000;48:1183-94.

57. Ihl R, Bachinskaya N, Korczyn AD, et al. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry 2011;26:1186-94.

58. Krieglstein J. Neuroprotective properties of Ginkgo biloba—constituents. Zeitschrift Phytother 1994;15:92-6.

59. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan(Ginkgo biloba): Recent Results in Pharmacology and Clinic. Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.

60. Jung F, Mrowietz C, Kiesewetter H, Wenzel E. Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. Arzneimittelforschung 1990;40:589-93.

61. Schubert H, Halama P. Depressive episode primarily unresponsive to therapy in elderly patients; efficacy of Ginkgo biloba extract (EGb 761) in combination with antidepressants. Geriatr Forsch 1993;3:45-53.

62. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139-45.

63. Sohn M, Sikora R. Ginkgo biloba extract in the therapy of erectile dysfunction. J Sex Educ Ther 1991;17:53-61.

64. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139-43.

65. Sohn M, Sikora R. Ginkgo biloba extract in the therapy of erectile dysfunction. J Sex Educ Ther 1991;17:53-61.

66. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139-43.

67. Vorberg G. Ginkgo biloba extract (GBE): A long-term study of cerebral insufficiency in geriatric patients. Clin Trials J 1985;22:149-57.

68. Claussen CF. Diagnostic and practical values of craniocorpography in vertiginous syndromes. Presse Med 1986;15:1565-8 [in French].

69. Haguenauer JP, Cantenot F, Koskas H, Pierart H. Treatment of disturbances of equilibrium with Ginkgo biloba extract: A multicenter, double-blind, drug versus placebo study. Presse Med 1986;15:1569-72 [in French].

70. Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol 1999;24:164-7.

71. Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo-controlled trial. BMJ 2001;322:1-6.

72. Meyer B. A multicenter randomized double-blind study of Ginkgo biloba extract versus placebo in the treatment of tinnitus. In Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic, ed. EW Funfgeld. New York: Springer-Verlag, 1988, 245-50.

73. Morgenstern C, Biermann E. Ginkgo biloba special extract EGb 761 in the treatment of tinnitus aurium: Results of a randomized, double-blind, placebo-controlled study. Fortschr Med 1997;115:7-11.

74. Holgers K, Axelsson A, Pringle I. Ginkgo biloba extract from the treatment of tinnitus. Audiol 1994;33:85-92.

75. Clostre F. Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000. Ann Pharm Fr 1999 ;57:1S8-88 [review; in French].

76. Kudolo G, Wang W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study. Clin Nutr 2006;25:606–16.

77. Aziz T, Hussain S, Mahwi T, et al. The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial. Drug Des Devel Ther 2018;12:735–42.

78. Lu J, He H. Clinical observation of Gingko biloba extract injection in treating early diabetic nephropathy. Chin J Integr Med 2005;11:226–8. [in Chinese]

79. Huang S, Jeng C, Kao S, et al. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 2004;23:615–21.

80. Zhao Y, Yu J, Liu J, An X. The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications. Evid Based Complement Alternat Med 2016;2016:7931314.

81. da Silva G, Zanoni J, Buttow N. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011;17:898–905.

82. Taliyan R, Sharma P. Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats. Phytother Res 2012;26:1823–9.

83. Lanthony P, Cosson JP. The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study. J Fr Ophtalmol 1988;11:671-4 [in French].

84. Rhee K, Lee C, Kim S, et al. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice. Int J Med Sci 2015;12:987–94.

85. Bernardczyk-Meller J, Siwiec-Proscinska J, Stankiewicz W, et al. [Influence of Eqb 761 on the function of the retina in children and adolescent with long lasting diabetes mellitus—preliminary report]. Klin Oczna 2004;106:569–71.

86. Kim J, Yokoyama K, Araki S. The effects of Ginkgo biloba extract (GBe) on axonal transport microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats. Environ Health Prev Med 2000;5:53–9.

87. da Silva G, Zanoni J, Buttow N. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011;17:898–905.

88. Koltringer P, Langsteger W, Lind P, et al. [Ginkgo biloba extract and folic acid in the therapy of changes caused by autonomic neuropathy]. Acta Med Austriaca 1989;16:35–7 [in German].

89. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993;88:447-57 [in French].

90. Chung KF, McCusker M, Page CP, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1987;i:248-51.

91. Tamborini A, Taurelle R. Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993;88:447-57 [in French].

92. Guinot P, Brambilla C, Dunchier J, et al. Effect of BN 52063, a specific PAF-ascether antagonist, on bronchial provocation test to allergens in asthmatic patients—a preliminary study. Prostaglandins 1987;34:723-31.

93. Li M, Yang B, Yu H, Zhang H. Clinical observation of the therapeutic effect of ginkgo leaf concentrated oral liquor on bronchial asthma. Chinese J Integrative & Western Med 1997;3:264-7.

94. Parsad D, Pandhi R, Juneja A. Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 2003;28:285-7.

95. Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med 2011;11:21.

96. Blumenthal M, Busse WR, Goldberg A, et al, eds. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 136-8.

97. Matthews MK Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998;50:1933-4 [letter].

98. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997;336:1108 [letter].

99. Kellermann AJ, Kloft C. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy 2011;31:490-502.

100. Granger AS. Ginkgo biloba precipitating epileptic seizures. Age Ageing 2001;30:523-5.

101. Siegers CP. Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 1999;6:281-3.

102. Kudolo GB. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic ß-cell function in response to glucose loading in normal glucose-tolerant individuals. J Clin Pharmacol 2000;40:647-54.

103. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278:1327-32.

Copyright © 2025 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2025.